Walleye Capital LLC Buys 79,577 Shares of Nu Skin Enterprises, Inc. $NUS

Key Points

• Walleye Capital LLC increased its holdings in Nu Skin Enterprises by 31.2%, acquiring an additional 79,577 shares, bringing their total to 334,913 shares valued at approximately $2.43 million.
• Nu Skin Enterprises reported earnings per share of $0.43 for the last quarter, exceeding analyst expectations of $0.25, while also reporting a revenue of $386.14 million.
• The company announced a quarterly dividend of $0.06 per share, representing a 2.0% yield, with payment scheduled for September 10th.

Walleye Capital LLC boosted its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 31.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 334,913 shares of the company's stock after purchasing an additional 79,577 shares during the period. Walleye Capital LLC owned approximately 0.67% of Nu Skin Enterprises worth $2,431,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Two Sigma Investments LP grew its position in Nu Skin Enterprises by 24.2% in the 4th quarter. Two Sigma Investments LP now owns 700,500 shares of the company's stock worth $4,826,000 after purchasing an additional 136,624 shares during the period. Man Group plc grew its position in Nu Skin Enterprises by 125.5% in the 4th quarter. Man Group plc now owns 102,836 shares of the company's stock worth $709,000 after purchasing an additional 57,235 shares during the period. New York State Teachers Retirement System bought a new stake in Nu Skin Enterprises in the 1st quarter worth approximately $33,000. Wealth Enhancement Advisory Services LLC bought a new stake in Nu Skin Enterprises in the 1st quarter worth approximately $118,000. Finally, MetLife Investment Management LLC grew its position in Nu Skin Enterprises by 36.2% in the 4th quarter. MetLife Investment Management LLC now owns 30,429 shares of the company's stock worth $210,000 after purchasing an additional 8,091 shares during the period. Institutional investors own 82.84% of the company's stock.

Wall Street Analyst Weigh In

NUS has been the subject of a number of recent research reports. Wall Street Zen raised shares of Nu Skin Enterprises from a "buy" rating to a "strong-buy" rating in a research report on Friday, August 22nd. Zacks Research raised shares of Nu Skin Enterprises to a "hold" rating in a research report on Tuesday, August 12th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $6.88.

Insider Activity

In related news, Director Daniel W. Campbell sold 23,391 shares of the company's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $12.10, for a total transaction of $283,031.10. Following the transaction, the director directly owned 53,375 shares in the company, valued at approximately $645,837.50. This represents a 30.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.00% of the company's stock.

Nu Skin Enterprises Price Performance

NUS stock traded down $0.04 during mid-day trading on Tuesday, hitting $12.14. The company had a trading volume of 285,010 shares, compared to its average volume of 652,113. The company has a market capitalization of $600.68 million, a price-to-earnings ratio of 6.03 and a beta of 0.92. Nu Skin Enterprises, Inc. has a 12-month low of $5.32 and a 12-month high of $12.40. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The company has a 50-day moving average price of $9.62 and a 200 day moving average price of $8.04.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.25 by $0.18. The business had revenue of $386.14 million for the quarter, compared to analysts' expectations of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, research analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 10th. Stockholders of record on Friday, August 29th will be given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, August 29th. Nu Skin Enterprises's dividend payout ratio is currently 11.94%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.